A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
a statement of the study hypothesis:the effect of valsartan in patients with IgA nephropathy
have been proved,and the efficacy of probucol in combination with valsartan is to be proved
in patients with IgA nephropathy.
This is a prospective randomized controlled, double blinded pilot study to identify the
efficacy of probucol in combination with valsartan in patients with IgA nephropathy. The
renal function deterioration will be the primary outcome studied. The expected study duration
will be 36 months.
Phase:
Phase 4
Details
Lead Sponsor:
Guangdong General Hospital Guangdong Provincial People's Hospital